Lack of endothelial nitric oxide synthase decreases cardiomyocyte proliferation and delays cardiac maturation

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 6, 2006, Pages

  Lepic, Erin ^a   Burger, Dylan ^a   Lu, Xiangru ^a   Song, Wei ^a   Feng, Qingping ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Heart development; Proliferation

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BROXURIDINE; DIETHYLENETRIAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; MYOSIN HEAVY CHAIN ALPHA; N(G) NITROARGININE METHYL ESTER; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE CELL; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANIMALS, NEWBORN; ATRIAL NATRIURETIC FACTOR; BROMODEOXYURIDINE; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; HEART; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR MYOSINS;

EID: 33845292580     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00092.2006     Document Type: Article

References (29)

1. Balligand JL and Cannon PJ. Nitric oxide synthases and cardiac muscle: autocrine and paracrine influences. Arterioscler Thromb Vasc Biol 17: 1846-1858, 1997.
2. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, Grayzel D, Kroumpouzou E, Traill TA, Leblanc-Straceski J, Renault B, Kucherlapati R, Seidman JG, and Seidman CE. Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15: 30-35, 1997.
3. Basson CT, Huang T, Lin RC, Bachinsky DR, Weremowicz S, Vaglio A, Bruzzone R, Quadrelli R, Lerone M, Romeo G, Silengo M, Pereira A, Krieger J, Mesquita SF, Kamisago M, Morton CC, Pierpont ME, Muller CW, Seidman JG, and Seidman CE. Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci USA 96: 2919-2924, 1999.
4. Bloch W, Fleischmann BK, Lorke DE, Andressen C, Hops B, Hescheler J, and Addicks K. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 43: 675-684, 1999.
5. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, and Seidman JG. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106: 709-721, 2001.
6. Cluzeaut F and Maurer-Schultze B. Proliferation of cardiomyocytes and interstitial cells in the cardiac muscle of the mouse during pre- and postnatal development. Cell Tissue Kinet 19: 267-274, 1986.
7. Feng Q, Song W, Lu X, Hamilton JA, Lei M, Peng T, and Yee SP. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 106: 873-879, 2002.
8. Feucht M, Christ B, and Wilting J. VEGF induces cardiovascular malformation and embryonic lethality. Am J Pathol 151: 1407-1416, 1997.
9. Garg UC and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
10. Gregg AR, Schauer A, Shi O, Liu Z, Lee CG, and O'Brien WE. Limb reduction defects in endothelial nitric oxide synthase-deficient mice. Am J Physiol Heart Circ Physiol 275: H2319-H2324, 1998.
11. Haigh JJ, Gerber HP, Ferrara N, and Wagner EF. Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development 127: 1445-1453, 2000.
12. Hatcher CJ, Kim MS, Mah CS, Goldstein MM, Wong B, Mikawa T, and Basson CT. TBX5 transcription factor regulates cell proliferation during cardiogenesis. Dev Biol 230: 177-188, 2001.
13. Houweling AC, Somi S, Massink MP, Groenen MA, Moorman AF, and Christoffels VM. Comparative analysis of the natriuretic peptide precursor gene cluster in vertebrates reveals loss of ANF and retention of CNP-3 in chicken. Dev Dyn 233: 1076-1082, 2005.
14. Houweling AC, van Borren MM, Moorman AF, and Christoffels VM. Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease. Cardiovasc Res 67: 583-593, 2005.
15. Kanno S, Kim PK, Sallam K, Lei J, Billiar TR, and Shears LL 2nd. Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc Natl Acad Sci USA 101: 12277-12281, 2004.
16. Kardami E. Stimulation and inhibition of cardiac myocyte proliferation in vitro. Mol Cell Biochem 92: 129-135, 1990.
17. Kelly RA, Balligand JL, and Smith TW. Nitric oxide and cardiac function. Circ Res 79: 363-380, 1996.
18. Lee TC, Zhao YD, Courtman DW, and Stewart DJ. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 101: 2345-2348, 2000.
19. Li F, Wang X, Capasso JM, and Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28: 1737-1746., 1996.
20. Liu Q, Yan H, Dawes NJ, Mottino GA, Frank JS, and Zhu H. Insulin-like growth factor II induces DNA synthesis in fetal ventricular myocytes in vitro. Circ Res 79: 716-726, 1996.
21. Lompre AM, Nadal-Ginard B, and Mahdavi V. Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem 259: 6437-6446, 1984.
22. Papapetropoulos A, Garcia-Cardena G, Madri JA, and Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997.
23. Peng T, Lu X, and Feng Q. Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression. Circulation 111: 1637-1644, 2005.
24. Peng T, Lu X, Lei M, and Feng Q. Endothelial nitric-oxide synthase enhances lipopolysaccharide-stimulated tumor necrosis factor-alpha expression via cAMP-mediated p38 MAPK pathway in cardiomyocytes. J Biol Chem 278: 8099-8105, 2003.
25. Pepper MS, Ferrara N, Orci L, and Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189: 824-831, 1992.
26. Razavi HM, Hamilton JA, and Feng Q. Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther 106: 147-162, 2005.
27. Song W, Lu X, and Feng Q. Tumor necrosis factor-alpha induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes. Cardiovasc Res 45: 595-602, 2000.
28. Soonpaa MH, Kim KK, Pajak L, Franklin M, and Field LJ. Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol Heart Circ Physiol 271: H2183-H2189, 1996.
29. Swynghedauw B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol Rev 66: 710-771, 1986.